Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jul;9(7):569-78.
doi: 10.1016/j.jash.2015.05.005. Epub 2015 May 15.

Pharmacist intervention for blood pressure control: medication intensification and adherence

Affiliations
Randomized Controlled Trial

Pharmacist intervention for blood pressure control: medication intensification and adherence

Tyler H Gums et al. J Am Soc Hypertens. 2015 Jul.

Abstract

The objective of this study was to describe medication adherence and medication intensification in a physician-pharmacist collaborative management (PPCM) model compared with usual care. This study was a prospective, cluster, randomized study in 32 primary care offices from 15 states. The primary outcomes were medication adherence and anti-hypertensive medication changes during the first 9 months of the intervention. The 9-month visit was completed by 539 patients, 345 of which received the intervention. There was no significant difference between intervention and usual care patients in regards to medication adherence at 9 months. Intervention patients received significantly more medication changes (4.9 vs.1.1; P = .0003) and had significantly increased use of diuretics and aldosterone antagonists when compared with usual care (P = .01).The PPCM model increased medication intensification; however, no significant change in medication adherence was detected. PPCM models will need to develop non-adherence identification and intervention methods to further improve the potency of the care team.

Keywords: Collaboration; hypertension; team-based care.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Authors of this presentation have nothing to disclose concerning possible financial or personal relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation.

References

    1. CDC. Vital signs: prevalence, treatment, and control of hypertension—United States, 1999–2002 and 2005–2008. MMWR. 2011;60(4):103–108. - PubMed
    1. Yang Q, Cogswell ME, Flanders W, et al. Trends in Cardiovascular Health Metrics and Associations With All-Cause and CVD Mortality Among US Adults. JAMA. 2012;307(12):1273–1283. - PMC - PubMed
    1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303:2043–2050. - PubMed
    1. World Health Organization (WHO) Adherence to Long-term Therapies: Evidence for Action. [Accessed August 18, 2014];WHO website.
    1. Muntner P, Halanych JH, Reynolds K, et al. Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Clin Hypertens. 2011;13:479–486. - PMC - PubMed

Publication types

Substances